glp-1 glp-2 glp-3 differences The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology GLP-1 vs GLP-3: What's the

L.SmoligaJ

Soshould I try it

The American College of Physicians guidelines note that continued treatment is necessary to maintain weight loss, as discontinuation often leads to weight regain

Semaglutide and tirzepatide have also been linked to pancreatitis, gallbladder disease and, more rarely, kidney injury tied to severe dehydration from gastrointestinal (GI) side effects

Notably, this correlation was independent of presence of diabetes

In countries like Denmark, home to Novo Nordisk (Ozempic and Wegovys manufacturer), there are concerns about economic over-reliance on the pharmaceutical sector, to the extent a recent article from the National Public Radio (NPR 2024) has questioned whether Denmark is developing into a pharma state based on the Novo Nordisks chokehold on the Danish economy